PGI Endocrine training:

Recollection from another Arjuna
Sir, As alumni of PGIMER Chandigarh, we read with great interest the article by Das et al. [1] in the Arjuna's recollections section of the journal.
We were quite nostalgic and wished to place on record that we share almost all of the experiences which the authors have mentioned. There is very little doubt that the academic environment at PGIMER is one of the best in the world. Here, we would like to share our thoughts on the nonacademic facets of PGI training so that future doctors coming out of this great institution (as well as other top institutions in our country) are better prepared to face the challenges of the real world.
During PGI training, the candidate is usually in a closely knit protective environment with almost the whole time spent on clinical, academic, or research work. It is well known that after completion of the program, not everybody would continue to be in a similar academic institute or join government hospitals and pursue a research-oriented endocrine career. In fact, most of the candidates seek jobs in private sector, especially in corporate hospitals, and few of them would have a hospital/clinic set up of their own. I felt that during the training program, few sessions of discussion by experts on options available after leaving the institute and exposure to such set up may instill more confidence in the candidates as well as provide first-hand information on the "real" world outside the institute.
Again, some perspective or brief course on financial and human resource management would also help in providing and equipping the candidates holistically for a nonPGI-like set up. Above all, orientation and practical sessions on balancing family with academic life within and outside the institute need to be reiterated. The alumni meeting and exchange programs with other institutes (including private institutes) may be very helpful in this regard.
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There are no conflicts of interest. are found to be expressed in human muscle tissue. [1] Studies among older individuals suggested that Vitamin D receptor activation in muscle induces de novo protein synthesis. This effect is particularly seen in type II fast twitch muscle fibers. This finding proposed an association between muscle strengthening the effect of Vitamin D and prevention of fall. [2] Several studies have found the beneficiary impact of this vitamin on muscle strength. However, reversed results are also there. A meta-analyses of double-blind, randomized control trial (RCT) support a benefit of Vitamin D supplementation in the prevention of falls and hip fractures among patients of 65 years and older at high risk of Vitamin D deficiency. [3] However, questionable outcomes are also there in meta-analyses where this age restriction is not maintained. [4] Currently, we have come to know about another study (NCT01017354). It is a 1-year, double-blind, randomized clinical trial conducted in Zurich, Switzerland. Analysis of data was done from June 15, 2012, to October 10, 2015.
The study was done involving 200 community-dwelling men and women 70 years and older with a prior fall. [2] Participants were randomized to one of three study groups with monthly supplementation with Vitamin D3. The first one was the control group and received 24,000 IU of Vitamin D3 monthly. The second group was given 60,000 IU of Vitamin D3. The third group received 24,000 IU of Vitamin D3 plus 300 μg of calcifediol. The first group and the third group had significantly higher percentages of patients with fall compared with the second group at 12 months. [2] In this RCT, older age group participants receiving higher dose Vitamin D3 did not experience improved lower extremity function. Rather, they had the highest percentages of fallers compared with the control group (24,000 IU). [2] However, this study has some limitations also. History of prior fall in study group has increased a risk of functional decline to some extent. Another point is that this study lacks a placebo group. [2] We should be hopeful about two upcoming trials VITAL (the Vitamin D and Omega-3 Trial) and DO-HEALTH (the Vitamin D3-Omega-3-Home Exercise-Healthy Ageing and Longevity Trial) to provide some more information about Vitamin D action. [2] Financial support and sponsorship
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